About Maxiplus

MAXIPLUS MEDICAL & PHARMACEUTICAL has established itself as Isreal's leading pharmaceutical company that researches, develops and manufactures medicines and medical equipments to compete in the global market by engaging in a wide range of partnerships with leading healthcare companies worldwide and building the most number of regional infrastructures compared to other Isreali firms.

In particular, we have obtained International Standard Certifications including the environmental management systems (ISO 14001), occupational health and safety systems (ISO 45001), and quality management systems (ISO 9001). We have acquired GMP Certifications from regulatory agencies of developed countries such as the US Food and Drug Administration (FDA) and European Medicines Agency (EMA), demonstrating our highly developed quality management system.

We strive endlessly to fulfill our goal of producing the world's first-in-class and best-in-class new drug through continuous R&D investment and open collaboration. Our unceasing effort is channeled towards diversifying our new drug pipeline and platform technology to ultimately progress human health and quality of life.

Based on the management principle that the “company grows as its employees grow”, Maxiplus practices a Smart-Work Office to foster an autonomous and immersive work environment, in addition to introducing Career Development Program (CDP), flexible working, and Maxiplus Global Talent Program. We are dedicated to cultivating industry-leading corporate culture and institution.

MAXIPLUS MEDICAL & PHARMACEUTICAL AND MEDICAL EQUIPMENT MANUFACTURING aspires to move beyond its title as Isreal's leading pharmaceutical company to become a healthcare group of global reputation. We will promote sustainable future growth by strengthening internal stability through responsible management, and responding quickly and flexibly to external environmental changes.
MAXIPLUS will devote itself to become a global healthcare group that creates new values to advance human health and quality of life based on continuous innovation.

Thank you.